{"id":17,"date":"2024-04-04T05:10:46","date_gmt":"2024-04-04T02:10:46","guid":{"rendered":"https:\/\/sisu.ut.ee\/rvv\/kasutatud-allikad\/"},"modified":"2025-03-27T18:19:33","modified_gmt":"2025-03-27T16:19:33","slug":"kasutatud-allikad","status":"publish","type":"page","link":"https:\/\/sisu.ut.ee\/rvv\/kasutatud-allikad\/","title":{"rendered":"Kasutatud allikad"},"content":{"rendered":"<ul>\n<li>U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Avaneb <a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/rr\/rr7304a1.htm\">siit<\/a>.<\/li>\n<li>Centers for Disease Control and Prevention. Ten great public achivements. MMWR Morb Mortal Wkly Rep 1999;48:241-3.<a href=\"http:\/\/dspace.ut.ee\/bitstream\/handle\/10062\/29445\/%20http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00056796.htm\" target=\"_blank\" rel=\"noopener\">\u00a0http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00056796.htm<\/a><\/li>\n<li>Dinger et al. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception 2016;94:328\u201339.<\/li>\n<li>European Society of Contraception and reproductive Health. Teaching and Training Tool for Contraceptive Methods. K\u00e4ttesaadav:\u00a0<a href=\"https:\/\/escrh.eu\/education\/training-improvement-programme\/\">https:\/\/escrh.eu\/education\/training-improvement-programme\/<\/a><\/li>\n<li>Guillebaud J. Contraception \u2013 your questions answered. 5th edition. Elsevier, 2009.<\/li>\n<li>Guillebaud J. Contraception today. 6th edition. Informa Healthcare, 2007.<\/li>\n<li>Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study. British Medical Journal 2007;335:651\u20139.<\/li>\n<li>International Consortium for Emergency Contraception, FIGO. Emergency Contraceptive Pills: Medical and Service Delivery Guidelines, 2012.<\/li>\n<li>Jacobstein R, et al. Progestin-only contraception: Injectables and implants. Best Practice &amp; Research in Clinical Obstetrics and Gynaecology 2014; 28: 795-806.<\/li>\n<li>Lidegaard \u00d8, Milson I, Geirsson RT, Skjeldestad FE. Hormonal contraception and venous thromboembolism. Acta Obstetricia et Gynecologica Scandinavica 2012;91:769\u201378.<\/li>\n<li>Long acting resersible contraception. NICE guidelines 2014. K\u00e4ttesaadav:\u00a0<a href=\"http:\/\/www.nice.org.uk\/guidance\/cg3\" target=\"_blank\" rel=\"noopener\">http:\/\/www.nice.org.uk\/guidance\/cg3<\/a><\/li>\n<li>Royal College of Obstetricians and Gynaecologists- Faculty of Sexual and Reproductive Healthcare guideline. \u00a0Emergency contraception. March 2017.<\/li>\n<li>Sexual rights: an IPPF declaration.\u00a0<a title=\"\" href=\"http:\/\/ippf.org\/resources\/publications\/sexual-rights-ippf-declaration\" target=\"_blank\" rel=\"noopener\" data-url=\"http:\/\/ippf.org\/resources\/publications\/sexual-rights-ippf-declaration\">http:\/\/ippf.org\/resources\/publications\/sexual-rights-ippf-declaration<\/a><\/li>\n<li>Van Vlijmen E et al. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemostat 2016;1393\u20131403.<\/li>\n<li>Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968\u20132004. British Journal of Cancer 2006;95:385\u20139.<\/li>\n<li>World Health Organisation. Medical eligibility criteria for contraceptive use. Geneva: WHO, 2009.\u00a0<a href=\"http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9789241563888\/en\/index.html\" target=\"_blank\" rel=\"noopener\">http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9789241563888\/en\/index.html<\/a><\/li>\n<li>World Health Organization Department of Reproductive Health and Research (WHO\/RHR) and Johns Hopkins Bloomberg School of Public Health\/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2011 update). Baltimore and Geneva: CCP and WHO, 2011.<\/li>\n<li>WHO. Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use. Third edition, 2016 K\u00e4ttesaadav:\u00a0<a href=\"http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9241562846index\/en\/index.html\" target=\"_blank\" rel=\"noopener\">http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9241562846index\/en\/index.html<\/a><\/li>\n<li>WHO. Medical eligibility criteria for contraceptive use. Fifth edition 2015. K\u00e4ttesaadav:<strong>\u00a0\u00a0<\/strong><a href=\"http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/MECguidelinePart-2.pdf?ua=1\" target=\"_blank\" rel=\"noopener\">http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/MECguidelinePart-2.pdf?ua=1<\/a><\/li>\n<\/ul>\n<p>Fotod:<\/p>\n<ul>\n<li>Timothy Takemoto\u00a0<a>http:\/\/commons.wikimedia.org\/wiki\/File:Condom_traffic_light.jpg<\/a><\/li>\n<li>Spiraalid \u2013 Bayer AG<\/li>\n<li>\u00dclej\u00e4\u00e4nud fotod \u2013 Triin Marandi<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Avaneb siit. Centers for Disease Control and Prevention. Ten great public achivements. MMWR Morb Mortal Wkly Rep 1999;48:241-3.\u00a0http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00056796.htm Dinger et al. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. &#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-17","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/pages\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/comments?post=17"}],"version-history":[{"count":3,"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/pages\/17\/revisions"}],"predecessor-version":[{"id":114,"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/pages\/17\/revisions\/114"}],"wp:attachment":[{"href":"https:\/\/sisu.ut.ee\/rvv\/wp-json\/wp\/v2\/media?parent=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}